Cardiometabolic multimorbidity prevalence and its socio-demographic determinants among Iranian adults: insights from the nationwide STEPS 2021
Nearly 15% of Iranian adults have multiple cardiometabolic conditions simultaneously, with post-COVID hospitalization emerging as a novel risk factor.
14.43% of Iranian adults have cardiometabolic multimorbidity (≥2 of: hypertension, type 2 diabetes, MI/stroke) based on a large nationwide survey of 16,453 adults, with comparable prevalence between sexes. The study provides country-level benchmarks for a high-burden middle-income country and identifies COVID-19 hospitalization history as a novel positive determinant, warranting further investigation of post-COVID cardiometabolic risk.
What the study was
- Study design
- Cross-sectional nationwide survey (WHO STEPS 2021)
- Population
- Iranian adults aged 25-75 years; nationwide sample
- Sample size
- 16453
- Category
- Public Health
- Maturity
- Validated
- Journal
- Scientific Reports
Why it surfaced
Large nationally representative survey provides cardiometabolic multimorbidity benchmarks for a LMIC with limited prior data; COVID-19 hospitalization as a novel determinant is an interesting signal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.